
Oct 2nd 2024
Novel mitophagy inducers and gene therapies that restore cellular function and decelerate the ageing process.
Mar 4th 2024
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Dec 3rd 2023
The bio/pharmaceutical industry is struggling with the challenge of staffing and training.
Sep 2nd 2023
Pharma's ability to continually reinvent itself will be critical in growing future business operations.

June 15th 2023
Advanco’s acquisition of Vantage Consulting Group boosts its position as a provider of independent pharmaceutical serialization solutions.

June 15th 2023
The collaboration between the Pistoia Alliance and Matador Japan will work to accelerate research and promote access to a global pharmaceutical ecosystem.

June 15th 2023
Mendus and NorthX Biologics will work to develop and commercialize Mendus’ lead asset, vididencel, an allogeneic dendritic cell vaccine.

June 14th 2023
The deal, valued at more than $2 billion dollars, will see Quell Therapeutics develop various T-regulatory cell therapies for AstraZeneca.

June 12th 2023
World leaders have set ambitious goals to respond more swiftly to the next pandemic, including the US goal to design, test, and review a new vaccine just 100 days after a pandemic declaration.

June 8th 2023
The collaboration between Samsung Biologics and Pfizer will focus on long-term biosimilars manufacturing.

June 8th 2023
The complaint alleges that Medicaid price controls implemented in the Inflation Reduction Act will negatively impact biopharmaceutical innovation.

June 8th 2023
Sartorius and Waters will collaborate to develop integrated analytical solutions for downstream biomanufacturing.

May 30th 2023
Aragen and FAR Biotech will collaborate to advance a small-molecule neurodegeneration program.

May 30th 2023
The $87.5 million purchase grants Novartis rights to an investigational gene therapy program intended for treatment of cystinosis.